1
|
Smith J and Greaves I: Crush injury and
crush syndrome: A review. J Trauma. 54 (Suppl 5):S226–S230.
2003.PubMed/NCBI View Article : Google Scholar
|
2
|
Bosch X, Poch E and Grau JM:
Rhabdomyolysis and acute kidney injury. N Engl J Med. 361:62–72.
2009.PubMed/NCBI View Article : Google Scholar
|
3
|
Sever MS and Vanholder R: RDRTF of ISN
Work Group on Recommendations for the Management of Crush Victims
in Mass Disasters. Recommendation for the management of crush
victims in mass disasters. Nephrol Dial Transplant. 27 (Suppl
1):i1–i67. 2012.PubMed/NCBI View Article : Google Scholar
|
4
|
Obialo CI, Okonofua EC, Nzerue MC, Tayade
AS and Riley LJ: Role of hypoalbuminemia and hypocholesterolemia as
copredictors of mortality in acute renal failure. Kidney Int.
56:1058–1063. 1999.PubMed/NCBI View Article : Google Scholar
|
5
|
Bullock ML, Umen AJ, Finkelstein M and
Keane WF: The assessment of risk factors in 462 patients with acute
renal failure. Am J Kidney Dis. 5:97–103. 1985.PubMed/NCBI View Article : Google Scholar
|
6
|
Sever MS, Erek E, Vanholder R, Koc M,
Yavuz M, Aysuna N, Ergin H, Ataman R, Yenicesu M, Canbakan B, et
al: Lessons learned from the catastrophic Marmara earthquake:
Factors influencing the final outcome of renal victims. Clin
Nephrol. 61:413–421. 2004.PubMed/NCBI View
Article : Google Scholar
|
7
|
Chertow GM, Christiansen CL, Cleary PD,
Munro C and Lazarus JM: Prognostic stratification in critically ill
patients with acute renal failure requiring dialysis. Arch Intern
Med. 155:1505–1511. 1995.PubMed/NCBI
|
8
|
Gonzalez D: Crush syndrome. Crit Care Med.
33 (Suppl 1):S34–S41. 2005.PubMed/NCBI View Article : Google Scholar
|
9
|
Tanaka H, Oda J, Iwai A, Kuwagata Y,
Matsuoka T, Takaoka M, Kishi M, Morimoto F, Ishikawa K, Mizushima
Y, et al: Morbidity and mortality of hospitalized patients after
the 1995 Hanshin-Awaji earthquake. Am J Emerg Med. 17:186–191.
1999.PubMed/NCBI View Article : Google Scholar
|
10
|
Vanholder R, Sever MS, Smet M, Erek E and
Lameire N: Intervention of the renal disaster relief task force in
the 1999 Marmara, Turkey earthquake. Kidney Int. 59:783–791.
2001.PubMed/NCBI View Article : Google Scholar
|
11
|
Zhang L, Fu P, Wang L, Cai G, Zhang L,
Chen D, Guo D, Sun X, Chen F, Bi W, et al: The clinical features
and outcome of crush patients with acute kidney injury after the
Wenchuan earthquake: Differences between elderly and younger
adults. Injury. 43:1470–1475. 2012.PubMed/NCBI View Article : Google Scholar
|
12
|
Ashkenazi I, Isakovich B, Kluger Y, Alfici
R, Kessel B and Better OS: Prehospital management of earthquake
casualties buried under rubble. Prehosp Disaster Med. 20:122–133.
2005.PubMed/NCBI View Article : Google Scholar
|
13
|
Erek E, Sever MS, Serdengeçti K, Vanholder
R, Akoğlu E, Yavuz M, Ergin H, Tekçe M, Duman N and Lameire N:
Turkish Study Group of Disaster. An overview of morbidity and
mortality in patients with acute renal failure due to crush
syndrome: The Marmara earthquake experience. Nephrol Dial
Transplant. 17:33–40. 2002.PubMed/NCBI View Article : Google Scholar
|
14
|
Xue L, Wu Z, Ji XP, Gao XQ and Guo YH:
Effect and mechanism of salvianolic acid B on the myocardial
ischemia-reperfusion injury in rats. Asian Pac J Trop Med.
7:280–284. 2014.PubMed/NCBI View Article : Google Scholar
|
15
|
Kong R, Gao Y, Sun B, Chen H, Wang G, Wang
X, Zhu H, Pan S, Xue D and Jiang H: The strategy of combined
ischemia preconditioning and salvianolic acid-B pretreatment to
prevent hepatic ischemia-reperfusion injury in rats. Dig Dis Sci.
54:2568–2576. 2009.PubMed/NCBI View Article : Google Scholar
|
16
|
Tang M, Feng W, Zhang Y, Zhong J and Zhang
J: Salvianolic acid B improves motor function after cerebral
ischemia in rats. Behav Pharmacol. 17:493–498. 2006.PubMed/NCBI View Article : Google Scholar
|
17
|
Pan RH, Xie FY, Chen HM, Xu LZ, Wu XC, Xu
LL and Yao G: Salvianolic acid B reverses the
epithelial-to-mesenchymal transition of HK-2 cells that is induced
by transforming growth factor-β. Arch Pharma Res. 34:477–483.
2011.PubMed/NCBI View Article : Google Scholar
|
18
|
Han JY, Fan JY, Horie Y, Miura S, Cui DH,
Ishii H, Hibi T, Tsuneki H and Kimura I: Ameliorating effects of
compounds derived from Salvia miltiorrhiza root extract on
microcirculatory disturbance and target organ injury by ischemia
and reperfusion. Pharmacol Ther. 117:280–295. 2008.PubMed/NCBI View Article : Google Scholar
|
19
|
Watzke A, O'Malley SJ, Bergman RG and
Ellman JA: Reassignment of the configuration of salvianolic acid B
and establishment of its identity with lithospermic acid B. J Nat
Prod. 69:1231–1233. 2006.PubMed/NCBI View Article : Google Scholar
|
20
|
Liu Q, Shi X, Tang L, Xu W, Jiang S, Ding
W, Feng Q, Chu H, Ma Y, Li Y, et al: Salvianolic acid B attenuates
experimental pulmonary inflammation by protecting endothelial cells
against oxidative stress injury. Eur J Pharmacol. 840:9–19.
2018.PubMed/NCBI View Article : Google Scholar
|
21
|
Katary MA, Abdelsayed R, Alhashim A,
Abdelhasib M and Elmarakby AA: Salvianolic acid B slows the
progression of breast cancer cell growth via enhancement of
apoptosis and reduction of oxidative stress, inflammation, and
angiogenesis. Int J Mol Sci. 20(5653)2019.PubMed/NCBI View Article : Google Scholar
|
22
|
Huttunen S, Toivanen M, Liu C and
Tikkanen-Kaukanen C: . Novel anti-infective potential of
salvianolic acid B against human serious pathogen Neisseria
meningitidis. BMC Res Notes. 9(25)2016.PubMed/NCBI View Article : Google Scholar
|
23
|
Xinyue W, Wang L, Tang L, Wang L, Cao S,
Wu Q, Zhang Z and Li L: Salvianolic acid B alters the gut
microbiota and mitigates colitis severity and associated
inflammation. J Funct Foods. 46:312–319. 2018.
|
24
|
Murata I, Ooi K, Sasaki H, Kimura S,
Ohtake K, Ueda H, Uchida H, Yasui N, Tsutsui Y, Yoshizawa N, et al:
Characterization of systemic and histologic injury after crush
syndrome and intervals of reperfusion in a small animal model. J
Trauma. 70:1453–1463. 2011.PubMed/NCBI View Article : Google Scholar
|
25
|
Murata I, Ooi K, Shoji S, Motohashi Y, Kan
M, Ohtake K, Kimura S, Ueda H, Nakano N, Sonoda K, et al: Acute
lethal crush-injured rats can be successfully rescued by a single
injection of high-dose dexamethasone through a pathway involving
PI3K-Akt-eNOS signaling. J Trauma Acute Care Surg. 75:241–249.
2013.PubMed/NCBI View Article : Google Scholar
|
26
|
Murata I, Miyake Y, Takahashi N, Suzuki R,
Fujiwara T, Sato Y, Inoue Y, Kobayashi J and Kanamoto I: Low-dose
sodium nitrite fluid resuscitation prevents lethality from crush
syndrome by improving nitric oxide consumption and preventing
myoglobin cytotoxicity in kidney in a rat model. Shock. 48:112–118.
2017.PubMed/NCBI View Article : Google Scholar
|
27
|
Murata I, Abe Y, Yaginuma Y, Yodo K,
Kamakari Y, Miyazaki Y, Baba D, Shinoda Y, Iwasaki T, Takahashi K,
et al: Astragaloside-IV prevents acute kidney injury and
inflammation by normalizing muscular mitochondrial function
associated with a nitric oxide protective mechanism in crush
syndrome rats. Ann Intensive Care. 7(90)2017.PubMed/NCBI View Article : Google Scholar
|
28
|
Brinkmann V, Reichard U, Goosmann C,
Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y and Zychlinsky A:
Neutrophil extracellular traps kill bacteria. Science.
303:1532–1535. 2004.PubMed/NCBI View Article : Google Scholar
|
29
|
Fuchs TA, Bhandari AA and Wagner DD:
Histones induce rapid and profound thrombocytopenia in mice. Blood.
118:3708–3714. 2011.PubMed/NCBI View Article : Google Scholar
|
30
|
Lin C, Liu Z, Lu Y, Yao Y, Zhang Y, Ma Z,
Kuai M, Sun X, Sun S, Jing Y, et al: Cardioprotective effect of
Salvianolic acid B on acute myocardial infarction by promoting
autophagy and neovascularization and inhibiting apoptosis. J Pharm
Pharmacol. 68:941–952. 2016.PubMed/NCBI View Article : Google Scholar
|
31
|
Chang PN, Mao JC, Huang SH, Ning L, Wang
ZJ, On T, Duan W and Zhu YZ: Analysis of cardioprotective effects
using purified Salvia miltiorrhiza extract on isolated rat
hearts. J Pharmacol Sci. 101:245–249. 2006.PubMed/NCBI View Article : Google Scholar
|
32
|
Li Y, Zhang X, Cui L, Chen R, Zhang Y,
Zhang C, Zhu X, He T, Shen Z, Dong L, et al: Salvianolic acids
enhance cerebral angiogenesis and neurological recovery by
activating JAK2/STAT3 signaling pathway after ischemic stroke in
mice. J Neurochem. 143:87–99. 2017.PubMed/NCBI View Article : Google Scholar
|
33
|
Paller MS, Hoidal JR and Ferris TF: Oxygen
free radicals in ischemic acute renal failure in the rat. J Clin
Invest. 74:1156–1164. 1984.PubMed/NCBI View Article : Google Scholar
|
34
|
Sharma OP and Bhat TK: DPPH antioxidant
assay revisited. Food Chem. 113:1202–1205. 2009.
|
35
|
Cockerill FR, Hindler JA, Wikler MA, Patel
JB, Alder J, Powell M, Dudley MN, Swenson JM, Eliopoulos GM,
Thomson RB, et al: Methods For Dilution Antimicrobial
Susceptibility Tests For Bacteria That Grow Aerobically; Approved
Standard. CLSI M7-A9. Vol 32. 9th edition. Clinical Laboratory
Standards Institute, Wayne, PA, 2012.
|
36
|
Scaffidi P, Misteli T and Bianchi ME:
Release of chromatin protein HMGB1 by necrotic cells triggers
inflammation. Nature. 418:191–195. 2002.PubMed/NCBI View Article : Google Scholar
|
37
|
Lotze MT and Tracey KJ: High-mobility
group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal.
Nat Rev Immunol. 5:331–342. 2005.PubMed/NCBI View Article : Google Scholar
|
38
|
Wang H, Bloom O, Zhang M, Vishnubhakat JM,
Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et
al: HMG-1 as a late mediator of endotoxin lethality in mice.
Science. 285:248–251. 1999.PubMed/NCBI View Article : Google Scholar
|
39
|
Murata I, Imanari M, Komiya M, Kobayashi
J, Inoue Y and Knamoto I: Icing treatment in rats with crush
syndrome can improve survival through reduction of potassium
concentration and mitochondrial function disorder effect. Exp Ther
Med. 19:777–785. 2020.PubMed/NCBI View Article : Google Scholar
|
40
|
Fiuza C, Bustin M, Talwar S, Tropea M,
Gerstenberger E, Shelhamer JH and Suffredini AF:
Inflammation-promoting activity of HMGB1 on human microvascular
endothelial cells. Blood. 101:2652–2660. 2003.PubMed/NCBI View Article : Google Scholar
|
41
|
Yang Q, Wang S, Xie Y, Wang J, Li H, Zhou
X and Liu W: Effect of salvianolic acid B and paeonol on blood
lipid metabolism and hemorrheology in myocardial ischemia rabbits
induced by pituitruin. Int J Mol Sci. 11:3696–3704. 2010.PubMed/NCBI View Article : Google Scholar
|
42
|
Ren M, Wang YM, Zhao J, Zhao J, Zhao ZM,
Zhang TF, He J, Ren SP and Peng SQ: Metallothioneins attenuate
paraquat-induced acute lung injury in mice through the mechanisms
of anti-oxidation and anti-apoptosis. Food Chem Toxicol.
73:140–147. 2014.PubMed/NCBI View Article : Google Scholar
|
43
|
Liu Y, Hu Y, E Q, Zuo J, Yang L and Liu W:
Salvianolic acid B inhibits mitochondrial dysfunction by
up-regulating mortalin. Sci Rep. 7(43097)2017.PubMed/NCBI View Article : Google Scholar
|
44
|
Huang M, Wang P, Xu S, Xu W, Xu W, Chu K
and Lu J: Biological activities of salvianolic acid B from
Salvia miltiorrhiza on type 2 diabetes induced by high-fat
diet and streptozotocin. Pharm Biol. 53:1058–1065. 2015.PubMed/NCBI View Article : Google Scholar
|
45
|
Zhao DH, Wu YJ, Liu ST and Liu RY:
Salvianolic acid B attenuates lipopolysaccharide-induced acute lung
injury in rats through inhibition of apoptosis, oxidative stress
and inflammation. Exp Ther Med. 14:759–764. 2017.PubMed/NCBI View Article : Google Scholar
|
46
|
Li W, Qian J, Liu X, Zhang Q, Wang L, Chen
D and Lin Z: Management of severe crush injury in a front-line tent
ICU after 2008 Wenchuan earthquake in China: An experience with 32
cases. Crit Care. 13(R178)2009.PubMed/NCBI View
Article : Google Scholar
|
47
|
Hong CH: Current understanding in
neutrophil differentiation and heterogeneity. Immune Netw.
17:298–306. 2017.PubMed/NCBI View Article : Google Scholar
|
48
|
Zarbock A, Ley K, McEver RP and Hidalgo A:
Leukocyte ligands for endothelial selectins: Specialized
glycoconjugates that mediate rolling and signaling under flow.
Blood. 118:6743–6751. 2011.PubMed/NCBI View Article : Google Scholar
|
49
|
Lee YW, Kim DH, Jeon SJ, Park SJ, Kim JM,
Jung JM, Lee HE, Bae SG, Oh HK, Son KH and Ryu JH: Neuroprotective
effects of salvianolic acid B on an Aβ25-35 peptide-induced mouse
model of Alzheimer's disease. Eur J Pharmacol. 704:70–77.
2013.PubMed/NCBI View Article : Google Scholar
|
50
|
Baggiolini M, Dewald B and Moser B:
Interleukin-8 and related chemotactic cytokines-CXC and CC
chemokines. Adv Immunol. 55:97–197. 1994.PubMed/NCBI
|
51
|
Mukaida N, Hishinuma A, Zachariae CO,
Oppenheim JJ and Matsushima K: Regulation of human interleukin 8
gene expression and binding of several other members of the
intercrine family to receptors for interleukin-8. Adv Exp Med Biol.
305:31–38. 1991.PubMed/NCBI View Article : Google Scholar
|
52
|
Gonzalez-Aparicio M and Alfaro C:
Influence of interleukin-8 and neutrophil extracellular trap (NET)
formation in the tumor microenvironment: Is there a pathogenic
role? J Immunol Res. 2019(6252138)2019.PubMed/NCBI View Article : Google Scholar
|
53
|
Parker H, Albrett AM, Kettle AJ and
Winterbourn CC: Myeloperoxidase associated with neutrophil
extracellular traps is active and mediates bacterial killing in the
presence of hydrogen peroxide. J Leukoc Biol. 91:369–376.
2012.PubMed/NCBI View Article : Google Scholar
|
54
|
Papayannopoulos V and Zychlinsky A: NETs:
A new strategy for using old weapons. Trends Immunol. 30:513–521.
2009.PubMed/NCBI View Article : Google Scholar
|
55
|
Fuchs TA, Abed U, Goosmann C, Hurwitz R,
Schulze I, Wahn V, Weinrauch Y, Brinkmann V and Zychlinsky A: Novel
cell death program leads to neutrophil extracellular traps. J Cell
Biol. 176:231–241. 2007.PubMed/NCBI View Article : Google Scholar
|